- Widespread resistance to current antimalarial drugs has sparked the urgent need for new effective treatments, leading researchers to explore drug repositioning as a cost-effective strategy.
- A computer-assisted drug repositioning approach identified seven promising drug candidates, with epirubicin being highlighted for further testing due to its strong effectiveness against both drug-sensitive and resistant malaria strains.
- Experimental validation revealed that epirubicin not only kills malaria parasites but also blocks their transmission, and further studies aim to understand its mechanism of action, suggesting it could be optimized for use in malaria treatment.